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EXECUTIVE SUMMARY 
Female genital mutilation/cutting (FGM/C) continues to be a threat to women’s and girls’ health 
and human rights globally. A sizeable body of evidence has developed over the past three 
decades on the direct health impacts of FGM/C. However, the evidence has been spread out and 
detached in diverse research, interventional, and training materials, making it cumbersome for 
quick reference when responding to women and girls exposed to the health effects of FGM/C. 
The Africa Coordinating Centre for the Abandonment of Female Genital Mutilation/Cutting 
(ACCAF), with support from the Population Council, sought to synthesize the evidence on the 
health impacts of FGM/C, identify recommended interventions, and compile and analyse the 
existing reference materials.  
The goal of the review was to inform the development of a comprehensive set of training 
guidelines and materials for frontline health care providers so they can manage the care of 
women and girls who have undergone FGM/C, prevent the practice at the community level, and 
accelerate abandonment of FGM/C practices. An analysis of existing systematic reviews, meta-
analyses, and published studies on health impacts associated with FGM/C and their specific 
interventions was conducted. A content analysis of 44 reference materials related to FGM/C was 
conducted using an updated data abstraction form that included 17 review criteria. Descriptive 
statistics were applied to the generated data to understand the components of the analysed 
documents.  A review and validation of the outcomes and interventions were carried out by 
medical experts on the ACCAF team.  
The health impacts associated with FGM/C that require interventions have been broadly 
categorised into: immediate, genito-urinary, gynecological, obstetric, sexual and psycho-social 
consequences. An analysis of existing training and research reference materials on FGM/C 
management showed major strength in epidemiology, but scored marginally on physical, 
gynecological, and obstetric complications. In addition, the reference materials scored poorly on 
the sexual and psycho-social impacts of FGM/C. Curative and preventive interventional 
approaches are recommended in the review for the various health consequences. Specifically, 
capacity building for health care providers to respond to women exposed to FGM/C in both health 
care facility and community settings should be prioritized. In addition, strengthening the health 
care systems by anchoring FGM/C interventions to existing programs and socio-community 
structures, especially in high prevalence areas, and by establishing supervisory mechanisms, 
protocols, documentation, and referral systems where expert care is lacking, among other 
interventions, will greatly help the response to the needs of cut women and girls while preventing 
new FGM/C cases.  
This analysis underscores the health impacts associated with FGM/C and compelling reasons for 
their interventions. Overall, the recommended interventions were informed by recommended 
best practices based on study reports, experts, and the strength of the available evidence. 
Women’s health is a human rights issue and women’s empowerment cannot be separated from 
issues related to women’s health. Therefore, a comprehensive, user-friendly training guide is 
required. Moving forward, Evidence to End FGM/C: Research to Help Girls and Women Thrive 
plans to collaboratively review existing curricula and related materials for health professionals 
before these much-needed training materials and guidelines for health care providers can be 
drafted; and to conduct new research to deepen understanding on all the health impacts of 
FGM/C and their interventions. 
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1.0 BACKGROUND 
1.1 Context  
Female genital mutilation/cutting (FGM/C) is a culturally entrenched global practice that not only 
is considered an evident human rights violation but also has resultant health and social 
repercussions on girls and women. It has been implicated in serious health consequences, 
significant morbidity, health burden, and poor health indicators [1, 2].  A sizeable body of 
evidence has been developed over the past three decades on the direct health impacts of 
FGM/C. Systematic reviews by the Norwegian Knowledge Centre for the Health Services provide 
a useful summary of these impacts, organized into obstetric, gynecological, and immediate 
health consequences depending on the type of FGM/C [3]. There are four documented types of 
FGM/C: clitoridectomy (type 1), the partial or total removal of the clitoris and prepuce; excision 
(type II), the partial or total removal of the clitoris and the labia minora; infibulations (type III), the 
narrowing of the vaginal orifice through creation of a covering seal by cutting and placing 
together the inner and/or outer labia with or without the removal of the clitoris; and others (type 
IV), including non-therapeutic harmful procedures to the female genitalia such as pricking, 
piercing, incising, scraping, and cauterization [2]. Researchers have alluded to the fact that 
FGM/C has also been associated with social, sexual, psychological, and mental consequences 
for women and girls.  
To enable health practitioners to address the consequences associated with FGM/C, WHO, 
various ministries of health, organizations, and experts have presented information in the form of 
training and intervention materials. Currently, however, there is no single comprehensive 
reference material and practitioners are required to consult various materials when faced with an 
FGM/C challenge. This can be inefficient and wasteful in terms of time for both clients and 
providers, and in some cases may result in serious complications or the loss of life. Therefore, a 
comprehensive package of interventions, skills support, and training materials on health impacts 
associated with FGM/C would be most useful to health practitioners. Such materials would 
support the provision of appropriate, efficient, and effective gynecological, obstetric, medical, 
and related treatment services, including preventive strategies.  
This synthesis has been spearheaded by the ACCAF team, with support from the Population 
Council and in consultation with recognized professional experts in the field of FGM/C, including 
WHO and FIGO. 
 
1.2 Rationale  
This review synthesis describes the health consequences of FGM/C, identifies recommended 
interventions, and assesses existing interventional and training materials with an aim toward 
informing a formal review of curricula and the development of user-friendly materials for 
mitigating the health consequences of FGM/C. The review is composed of three components: the 
health impacts associated with FGM/C, the medical and socio-community interventions 
recommended for the consequences, and analyses of FGM/C reference materials for inculcating 
knowledge, management skills, and prevention of the practice by health practitioners. The 
components of this review document are interrelated and are intended to synergize each other 
seamlessly.  
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2.0 APPROACH AND METHODS 
2.1 Objectives 
The ultimate goals of this review are to support recommendations for the development of 
appropriate, user-friendly training materials and resources for use in medical training colleges for 
trainee health providers; and to inform the in-service and/or continuous medical education for 
health care providers already working in high-prevalence FGM/C areas, for appropriate corrective 
as well as preventive interventions in the various settings.  
To achieve this goal, the following specific objectives were addressed: 
i. Review existing systematic reviews, meta-analyses, and published studies to identify the 
strongest evidence concerning FGM/C-related health outcomes for which interventions 
could be recommended. 
 
ii. Identify medical and socio-community interventions that have been recommended for the 
health consequences associated with FGM/C and its prevention. 
 
iii. Compile, review, and identify strengths and weaknesses of existing reference materials 
and propose improvements that would enhance pre-service training for frontline health 
care providers and that could be adapted for in-service training courses. 
 
2.2 Desk review 
The review of the literature was conducted using the terms “female genital mutilation,” “female 
genital cutting,” or “female circumcision” combined with medical subject heading (MeSH) terms 
“obstetrics,” “gynecologic,” psychologic,” and “women’s health” and keywords “health impacts,” 
“health effects,” “health outcomes,” “health consequences,” “interventions,” “training manual,” 
and “training guidelines.” Databases, including PubMed/MEDLINE, were searched applying the 
following parameters: year of publication between 1985 and 2015; human; and in the English 
language. The titles and abstracts of all articles identified through the literature search were 
scanned for relevance. Documents were selected for full review if they specifically mentioned 
FGM/C and reported data on health impacts, interventions, prevention, and training materials 
related to FGM/C. Human observational studies were reviewed, including cross-sectional, case-
control, prospective, and comparative studies; meta-analyses conducted on existing studies data; 
and cohort or population-based studies that used quantitative methodology. The respondents 
included women, girls, and health professionals, such as obstetricians, gynecologists, nurses, 
midwives, and researchers. The review included health impacts associated with FGM/C, 
recommended prevention and interventions to mitigate the health effects, and materials that 
should be included in training as a requirement for health care providers to care for women and 
girls affected by FGM/C and for prevention of the practice. Publications were excluded if they 
used qualitative study designs because of the non-randomized nature of sampling techniques 
and the pitfalls thereof; were not in English and could not be translated by default language 
translation software; or were more than 30 years old. 
 
Quality measures for considering the systematic reviews and research reports included: sample 
description (details included women and girls with all types of FGM/C, nationality, and age of 
respondents); sampling method (description of site/setting and sampling procedure); credibility 
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of researcher/author (professional midwife, nurse, obstetrician, gynecologist, surgeon, or 
researcher); and whether or not the systematic reviews were reviewed by content experts. 
Additionally, the reviewed papers offered citation sources for health outcomes, their 
interventions, and prevention and training guidelines for health professionals. These citations 
were subjected to PubMed/MEDLINE databases for retrieval and scrutinized to meet the 
aforementioned criteria. To supplement this process, other literature and training materials that 
were not available online were obtained from ACCAF, Population Council, and subject matter 
experts. Data were extracted and then any inconsistencies were resolved by checking full-text 
versions of the documents, counterchecking against the latest literature, and discussing with 
field experts.  
 
2.3 Data and analysis 
After reviewing relevant documents and 
identifying the FGM/C health consequences, 
the reference materials were compiled and 
scored, and recommended interventions were 
outlined. The compilation involved 
systematically assessing the evidence within 
the existing reference materials and 
published studies. The components of FGM/C 
in each individual piece of evidence were 
assessed using a standard data abstraction 
form that included 17 review criteria (Box 1). 
The criteria were developed based on a 
combination of different categories as 
provided in three guideline documents [4, 5, 
6] and formed the basis for analysing what 
should be included in comprehensive, user-
friendly training materials. 
Each individual reference material was 
assessed based on the presence of key 
components of FGM/C (Box 1). Their 
strengths and weaknesses were further 
determined based on details and depth of 
content material elaboration.  
A total of 44 reference materials were compiled, analysed, and categorised into three groups: 
interventional (73%; n=32), training materials (11%; n=5), and research reports (16%; n=7), 
respectively. The analyses of the materials involved ascertaining whether or not they captured 
the specific FGM/C components in the 17 review criteria. The analyses of the materials based 
on the criteria outlined in Box 1 yielded the following key insights as presented in Tables 1 and 
2.   
 
Box 1: Seventeen review criteria developed 
for assessing FGM/C reference materials  
 
No.  Criteria:  Key components of FGM/C        
Present=✔       Absent=O 
1 Background and description of FGM/C 
2 Complications of FGM/C  
3 FGM/C and human rights  
4 FGM/C management during pregnancy, labor, 
delivery, and postpartum period  
5 Management of girls and women with gynecological 
complications  
6 Management of girls and women with sexual 
complications  
7 Management of girls and women with 
psychological/mental complications  
8 Counseling  
9 Medicalization  
10 Professional ethics and legal implications of FGM/C  
11 Community involvement in prevention of FGM/C  
12 Community health education and advocacy  
13 FGM/C and family planning 
14 Referral procedure 
15 Research 
16 Training 
17 Monitoring and evaluation 
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Table 1. Percentage score of reference material based on 17 review criteria 
Percentage category (%) Score out of 17 Frequency n (%) 
75 and above 13-17 5 (10) 
50-74 9-12 6 (13) 
25-49 4-8 16 (33) 
0-24 0-3 21(44) 
Highest 15 (88%) 3 (7) 
Lowest 1 (6%) 5 (11) 
 
Table 2. The overall scores on specific FGM/C components for the reviewed reference materials  
S/No Components of FGM/C Scores, n (%) 
1 Background and description of FGM/C 42 (96) 
2 Complications of FGM/C  41 (93) 
3 FGM/C and human rights 29 (66) 
4 FGM/C management during pregnancy, labour, delivery, and postpartum 
period 
26 (59) 
5 Management of girls and women with gynecological complications 24 (55) 
6 Management of girls and women with sexual complications 19 (43) 
7 Management of girls and women with psychological/mental complications 18 (41) 
8 Counseling 22 (50) 
9 Medicalisation 26 (59) 
10 Professional ethics and legal implications of FGM/C 32 (73) 
11 Community involvement in prevention of FGM/C  25 (57) 
12 Community health education and advocacy 25 (57) 
13 FGM/C and family planning 11 (25) 
14 Referral procedure 16 (36) 
15 Research  23 (52) 
16 Training  14 (32) 
17 Monitoring and evaluation 11(25) 
 
Of the 44 reference materials analysed using the 17 review criteria for FGM/C components, the 
highest score was 15 (6.8%, n=3) while the lowest was 1 (11.4%, n=5) (Table 1). Only 10.4% 
(n=5) scored 75% and above, while 12.5% (n=6) scored 50 to 74% on the 17-point criteria. More 
than 75% (n=20) of the analysed reference materials contained less than 50% of the key FGM/C 
components. The highest (88.2%) score was 15, achieved by 6.8% (n=3), while the lowest (5.9%) 
score was 1, attained by 11.4% (n=5) of the reference materials, respectively. Only 25% (n=11) 
of the reference materials met 50% and above of the criteria. On the other hand, 40.9% (n=18) 
of the materials scored below 25% of the criteria.  
 
3.0 REVIEW FINDINGS 
3.1 Synthesis of evidence: Health impacts 
This section outlines the health impacts attributable to FGM/C as collected from the systematic 
reviews, meta-analyses, and published studies conducted in the past three decades. The review 
identified 5 categories of health impacts attributable to FGM/C: immediate, genito-urinary, 
obstetric, sexual, and psycho-social complications. The health impacts described in the sections 
below, based on available scientific evidence on FGM/C accumulated over the last three 
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decades, warrant interventions by health care providers in health facilities as well as in 
community settings.  
 
3.1.1 Immediate (acute) complications 
The cutting of women’s and girls’ clitoris and labia is usually done with crude unsterile 
instruments and without anesthesia, by traditional practitioners who have little knowledge of 
female anatomy [7]. The cutting results in immediate harm. Bleeding (haemorrhage) occurs due 
to laceration or severing of branches of the pudendal or clitoral arteries, which have high blood 
pressure, causing a strong flow of blood during and shortly after the cutting process. Other 
immediate complications include shock, genital tissue swelling, fever, infections, problems with 
urination (acute urinary retention, hesitancy), and delayed wound healing, as corroborated by 
observational studies involving large samples of women and girls of various ages who had 
undergone various types of FGM/C [3] and by study reports [8, 9]. Evidence also shows that girls 
suffer more than one immediate complication, and in some cases deaths have been attributed 
directly to FGM/C [10-14]. Death can result from severe bleeding, pain and trauma, severe and 
overwhelming infection, or a combination of these complications. The immediate harms vary with 
the type of FGM/C, with the greatest risk seen among type III, relative to types I and II [15] (Table 
3). 
The evidence on the magnitude of immediate complications associated with FGM/C varied 
across the reviewed studies. This variation may have been due to under-reporting of the 
complications or to the timing of post-procedure observations. Some studies have reported very 
high rates of girls who have undergone FGM/C but experienced no bleeding [15, 16]. Such 
disparities may be the result of methodological differences in data collection, with clinical 
assessment likely to be more objective and accurate, while self-reporting may result in gross 
under-reporting. This reasoning is supported by the fact that many women underwent FGM/C as 
infants or children and they may not remember any immediate adverse effects. Furthermore, 
women may not link complications arising during childbirth or later in life to the genital cutting 
they underwent as children. Additionally, FGM/C-related complications may be considered as 
normal and natural to women, especially among populations where FGM/C is nearly universal, 
due to social norms [17]. 
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Table 3. Immediate (acute) outcomes attributed to FGM/C 
Outcome 
Reasons Number of 
studies/type 
Sample 
size (n)  
(S)/(NS)1  References 
Bleeding 
Laceration to pudendal and/or clitoral 
arteries, which have high flow and 
pressure 
56/ 
Observational 
Representative 
133,515 S Berg et al. 
2014; 
Almroth et al. 
2005 
 
 
El Dareer 
1983; Trew 
2013; Migiro 
2014; Asuen 
1977; Badejo 
1983; Osifo & 
Evbuomwan 
2009 
 
 
 
Pain 
Injuries to cut tissues and nerves, swelling 
and pressure, no anesthesia 
Shock 
Blood loss (haemorrhagic shock), severe 
pain and trauma (neurogenic shock), which 
can be fatal 
Genital 
tissue 
swelling 
Trauma and injured tissues of urethra, 
vagina, perineum, and rectum 
Fever Inflammation, trauma, infection 
Infections 
Unsterile procedure, skin destruction (e.g., 
tetanus, hepatitis, HIV) 
Urination 
problems 
Swelling, inflammation around the wound, 
fear of pain of passing urine on the raw 
wound, or injury to the urethra 
Delayed 
wound 
healing 
Failure of wound to heal due to  infection, 
irritation from urine or rubbing when 
walking, or an underlying condition, such 
as anemia or malnutrition 
Death 
Severe bleeding, pain, and trauma, or 
severe and overwhelming infection, or a 
combination of the above 
 
3.1.2 Late (chronic) genito-urinary problems 
Female genital cutting is associated with chronic problems affecting the genital and/or urinary 
systems of women and girls. This has been corroborated by several comparative studies involving 
large numbers of women and girls [3, 18, 19]. The specific genito-urinary problems commonly 
reported include: genital tissue damage, vaginal discharge, itching, urological complications, and 
infections [3]. In light of this evidence, interventions for these complications should be 
developed. Other genito-urinary outcomes such as scarring, keloids, abscesses, fistulae, 
damaged tissue (perineum, anal sphincter), disfigurement, vaginal obstruction, and cysts are 
rarely encountered in the research reports, possibly because of lack of rigorous research and 
documentation [3]. This may be due to methodological differences in data collection and the fact 
that most studies do not disaggregate chronic genital urinary problems data against the type of 
cutting, which may affect the interpretation of the data [3] (Table 4). Additionally, some 
outcomes, such as HIV, STDs, and infertility, are rarely encountered in the literature and not 
reported.  
                                                          
1 S=significant; NS=not significant 
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Table 4. Late (chronic) genito-urinary outcomes attributed to FGM/C 
* The higher number represents case-control studies while the lower number represents cross-sectional studies.
                                                          
2 S=significant; NS=not significant. 
3 Dysmenorrhea, difficulty in menstruation, irregular menses, and difficulty in passing menstrual blood. 
Outcome 
Rationale for the 
outcome 
Study type Studies 
Sample 
size (n) 
(S) / 
(NS)2 
References 
Vaginal 
discharge 
Infections 
Cross-
sectional 
4 3,657 S 
Nwanjei & Otiono 2003; 
Okonofu et al. 2002; Elnashar 
& Abdelhady 2007 
Vaginal 
itching 
Infections, trauma, 
reaction due to 
discharge 
Cross-
sectional 
4 3,657 S 
Morrone et al. 2002; Okonofu 
et al. 2002; Elnashar & 
Abdelhady 2007 
Painful 
urination 
Damage to the 
urethral opening or 
scarring of the 
meatus 
Comparative 6 3,611 S 
Morison et al. 2001; Okonofu 
et al. 2002; Elnashar & 
Abdelhady 2007; De Silva 
1989 
Menstrual 
problems3  
Due to partial or total 
occlusion of the 
vaginal opening  
Cross-
sectional 
5 6,564 S 
INSEED 2005; El Defrawi et al. 
2001; Morrone et al. 2002; 
Nwajei & Al Otieono 2003 
Chronic 
genito-urinary 
infections 
Ascending urinary 
tract infections 
Comparative 10  28,940 S 
INSEED 2005; El Defrawi et al. 
2001; Fillo & Leone 2007 
Reproductive 
tract 
infections 
Occlusion of the 
vagina and urethra 
causing stasis and 
climbing of the 
infections 
Cross-
sectional 
 
Prospective 
2 2,412 
S 
 
Jones et al. 1999; Brewer et al. 
2007 
Genital 
infections 
Trauma, entry of 
infectious organisms, 
inflammation due to 
discharge 
Cross-
sectional 
 
Prospective 
2 2,412 S 
Jones et al. 1999; Brewer et al. 
2007 
Urinary tract 
Infections 
Occlusion of the 
urethra 
Meta-analyses 5 9,414 S  
INSEED 2005; El Defrawi et al. 
2001; Browning et al. 2010; 
Fillo & Leone 2007 
Bacterial 
vaginosis 
Trauma, entry of 
infectious organisms, 
reaction due to 
discharge 
Meta-analyses 5 9,414 S Nwajei & Otiono 2003 
Genital tissue 
damage 
Trauma due to 
FGM/C, inflammation 
due to discharge, 
infections 
Cross-
sectional 
4  3,657 NS  
Morison et al. 2001; Nwajei & 
Otiono 2003; Okonofu et al. 
2002; Elnashar & Abdelhady 
2007 
HIV 
Small vaginal 
opening, cuts and 
tears, sharing of 
cutting instruments 
Case-control 
 
Cross-
sectional 
1 
10* 
12,912 
NS 
NS 
Klouman et al. 2005; 
Maslovskaya et al. 2009; 
Yount & Abraham 2007; Balk 
2000 
STDs 
Trauma, entry of 
infectious organisms, 
inflammation due to 
discharge, poor 
hygiene due to pain 
Case-control 
 
Cross-
sectional 
1 
10* 
12,912 
NS 
NS 
Nwajei & Otiono 2003; 
Klouman et al. 2007; 
Maslovskaya et al. 2009; 
Yount & Abraham 2007; Balk 
2000 
Infertility 
Pelvic infections, 
damage to 
reproductive organs, 
painful intercourse  
Case-control 
 
Cross-
sectional 
2 
10* 
36,473  NS 
El Defrawi et al. 2001; 
Browning et al. 2010; Nwajei & 
Al Otiono 2003; Yount & 
Abraham 2007; Inhorn & Buss 
1993; Jackson et al. 2005; 
Larsen & Okonofua 2002; Berg 
& Underland 2013 
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In Table 4, the complications from the late (chronic) genito-urinary outcomes attributed to FGM/C 
were gleaned from systematic reviews and study reports. Corrective and preventive interventions 
for both common and rare outcomes are recommended at health facilities and in community 
settings.  
3.1.3 Obstetric complications 
The obstetric complications, notably prolonged labour, tears and lacerations, caesarean sections, 
episiotomies, instrumental deliveries, postpartum haemorrhages (PPHs), and difficult labour 
associated with FGM/C were documented from numerous comparative studies involving large 
samples of women and girls [3, 35, 36] (Table 5).  
Table 5. Obstetric outcomes attributed to FGM/C 
Outcome Type of study Number of 
studies 
Sample size (n) (S) / (NS) 4 References 
Prolonged 
labour 
Comparative 
 
Prospective 
5 
1 
715,079 
(6,324) 
S Berg et al. 2014; Berg & 
Underland 2013; Johnson 
et al. 2005; Chibber et al. 
2011; Meirik et al. 2006 
Tears and 
lacerations 
Comparative  
 
Prospective 
 
15 
 
738,672 
(17,961) 
S Berg et al. 2014; Berg & 
Underland 2013; Johnson 
et al. 2005; Chibber et al. 
2011; Meirik et al. 2006; 
Wuest et al. 2009 
Caesarean 
section 
Prospective 15 2.74M   
(41,306) 
S Berg et al. 2014; Johnson 
et al. 2005; Chibber et al. 
2011; Meirik et al. 2006; 
Wuest et al. 2009 
Episiotomy Retrospective 
 
Prospective 
11 
  
35,467 
(23,869) 
S Berg et al. 2014; Fillo & 
Leone 2007; Vangen et al. 
2002; Johnson et al. 2005; 
Chibber et al. 2011; Berg & 
Denison 2012 
Instrumental 
delivery 
Registry study 
 
Prospective 
 
Cross-section 
9 2.34M 
(12,557) 
S  Berg et al. 2014; Johnson 
et al. 2005; Chibber et al. 
2011 
Postpartum 
haemorrhage 
(PPH) 
 
Prospective 10 746,667 
(27,626) 
S  Berg et al. 2014; Johnson 
et al. 2005; Chibber et al. 
2011 
Difficult 
labour 
Prospective 
 
Cross section 
 
Comparative 
7 11,659 
(3,252) 
S  Berg et al. 2014; Berg et al. 
2014; Johnson et al. 2005; 
Chibber et al. 2011; Wuest 
et al. 2009 
 
In Table 5, the obstetric outcomes attributed to FGM/C are shown. These complications are 
associated with substantial suffering by women and girls. In the reference materials, it is 
recommended that corrective and preventive interventions be developed and/or strengthened at 
the health facility and community levels to deal with these consequences.  
 
                                                          
4 S=significant; NS=not significant. 
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3.1.4 Sexual functioning complications 
This synthesis revealed that FGM/C is associated with sexual complications. Women who had 
undergone cutting were more likely to report painful intercourse, no sexual desire, less sexual 
satisfaction, and less experience of orgasm compared to their uncut counterparts. Other sexual 
outcomes reported include women not initiating sex and lack of knowledge of the most sexually 
sensitive part of their bodies [42] (Table 6).  
Table 6. Sexual functioning outcomes attributed to FGM/C 
Outcome Number of 
studies 
Sample 
size (n) 
(S) 
/(NS) 5 
Reference 
Painful intercourse 
6 
3657* 
S 
Berg et al. 2014; El Defrawi et al. 2001; Morrone 
et al. 2002; Nwajei & Otiono 2003; Elnashar & 
Abdelhady 2007; De Silva 1989; Adinma 1997 
Satisfaction 
5 
S 
Morrone et al. 2002; Berg & Denison 2012; 
Adinma 1997; Alsibiani & Rouzi 2010 
Sexual desire 
2 
S 
Morrone et al. 2002; Adinma 1997; Thabet & 
Thabet 2003; Shandall 1967 
Experienced orgasm 
5 
S 
Adinma 1997; Thabet & Thabet 2003; Shandall 
1967; Megafu 1983; Rushwan 2000 
Initiated sex 
2 
NS 
Morrone et al. 2002; Elnashar & Abdelhady 
2007; Adinma 1997 
* Cross-sectional studies 
 
Table 6 outlines the sexual functioning outcomes attributed to FGM/C. The corrective and 
preventive interventions for sexual complications should include strategies for identification, 
management, monitoring, and prevention.  
 
3.1.5 Psycho-social complications 
FGM/C or its delayed complications may trigger the onset of one or a combination of the 
following complications: acute anxieties, depression, neuroses, psychoses, and post-traumatic 
stress disorder. The physical complications arising from FGM/C may also interfere with women’s 
and girls’ social lives because of ill health. For example, incontinence may interfere with their full 
participation in social activities and lead to isolation. Difficult penetration and infertility affect 
sexual life and may precipitate divorce [48]. The findings under this outcome were inconclusive 
because of the small number of studies that were reviewed, as well as the low quality of the 
methodological approach of the studies.  
 
                                                          
5 S=significant; NS=not significant 
10 
3.2 Synthesis of evidence: Curative and preventive interventions recommended 
for health impacts of FGM/C 
The review revealed various complications associated with FGM/C. This section outlines the 
interventions as recommended in these materials for alleviating and preventing FGM/C-
associated complications, both in health facilities and in socio-community settings. The section 
also forms the basis for reviewing existing interventions and/or training materials, curriculum, 
and capacity building for health professionals, with a view toward strengthening training 
materials and resources to provide better care for women and girls exposed to FGM/C and to 
prevent the practice.  
 
3.2.1 Training of health care professionals  
Public health services play a critical role in the prevention and mitigation of FGM/C and its 
harmful effects on women’s health. Thus the training of health care providers will be a key 
response. The materials recommend that training of health care professionals include 
comprehensive and technical knowledge about FGM/C to aid in promoting abandonment of 
FGM/C practices and to enable clinical management of those impacted by FGM/C. For example: 
 Frontline health care providers should be aware of the impacts, including immediate, 
physical, sexual, psychological, and social, associated with FGM/C and should consider 
the practice when assessing, managing, counseling, and/or referring women and girls for 
reproductive, pregnancy, and delivery health services.  
 As a result of the immediate (acute) nature of the complications caused by FGM/C, 
women and girls present to health facilities in very desperate conditions, requiring quick 
and effective interventions. It is recommended that health care professionals (doctors, 
nurses, and midwives) should be well-trained in the diagnosis and management of 
FGM/C-associated complications in patients who are admitted to or visit outpatient 
clinics immediately following genital cutting.  
 To deal with late (chronic) complications such as 
dermoid cysts and keloids, it is recommended that 
health professionals be trained to recognize, 
advise, counsel, and treat patients with these 
complications, as well as to perform curative 
procedures such as fistula repair and de-
infibulation [49-54].  
 It is recommended that hospitals in FGM/C-
endemic areas have their health care providers 
trained on caring for FGM/C-exposed women. 
Since infibulated women run the highest risk 
during labour, doctors, nurses, and midwives 
should be trained to develop expertise in the 
assessment and management of women with 
infibulations, including competencies to carry out 
de-infibulation and management after de-
infibulation (Box 2) [55, 56].  
 
Box 2: Example: Skill sets for de-
infibulation  
Recommendation: Women must undergo 
de-infibulation before conception, 
especially if difficult surgery is anticipated. 
 Doctors, nurses, and midwives are 
trained to develop expertise in the 
assessment and management of 
women with infibulations and following 
de-infibulation. 
 Clients are counseled that de-
infibulation can restore an opening to 
the vaginal canal to allow for normal 
urination, menstrual flow, and sexual 
intercourse. 
 Psychosexual counseling should be 
provided before and after de-
infibulation. 
 De-infibulation may be carried out in 
any suitable outpatient room equipped 
for minor procedures or in an operating 
theatre. 
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3.2.2 Provision of counseling and psycho-social support  
There is increasing evidence that “FGM and its associated health risks are psychological 
stressors that can lead to a variety of negative psychological and psychiatric outcomes” [57]. 
Recommendations for health care providers include the following: 
 Provide counseling and advice to clients based on anticipated complications associated 
with FGM/C, including encouraging women to deliver in a hospital with qualified 
assistance. 
 Recognize the underlying psychological complications of FGM/C and refer women and 
girls for appropriate psychological/counseling care.  
 Utilize cognitive behavioural therapy, which has been found to be effective in preventing 
and treating post-traumatic stress disorder.  
 Establish institutional, peer, and community-based counseling groups. 
 Recognize the sexual problems that women face as a result of FGM/C and routinely 
provide counseling for women with such complaints.  
 Initiate referral mechanisms, including linking clients with qualified sexologists. 
 Provide counseling and psycho-social support interventions for clients who access health 
facilities, as well as for those in community settings. The role of sexologists and sexual 
therapy should be pursued.  
 
3.2.3 Addressing social conventions and norms and creating awareness  
Health care providers play a key role in raising people’s awareness, bringing attention to the 
health impacts of FGM/C and encouraging behaviour change in the social conventions and 
norms that underpin the practices of FGM/C. The review illuminates the need to: 
 Enhance capacity of health care providers to raise awareness of the health impacts 
associated with FGM/C and encourage them in their roles as advocates, role models, 
counselors, and caretakers to contribute to the mitigation and abandonment of the 
practice [58-60]. 
 Anchor FGM/C preventive messages to existing reproductive health programs in health 
facilities, as well as in community settings, which will go a long way towards prevention 
and management of these complications.  
 Familiarize all maternity healthcare providers with the nature and higher rates of 
complications related to FGM/C.  
 Encourage women and girls to seek medical care if they have complications, because 
such complications may become intensified or even cause death, and also encourage 
them to avoid traditional remedies because the use of herbs can lead to severe bleeding 
or introduction of infections [48]. 
 Support health care providers in establishing community approaches to dealing with 
consequences of FGM/C (e.g., community psycho-social support, debriefings, and 
establishment of networks). 
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 Sensitize communities to the fact that some of the reproductive and medical 
complications women and girls present with at health service points are associated with 
FGM/C and that they can be traced to childhood trauma such as FGM/C. Raising 
awareness in this manner would enhance identification of the complications and lead to 
better-health seeking behaviour and promotion of preventive strategies. 
 Involve local administration, law enforcement, prosecutors, and the judiciary in raising 
awareness in communities about anti-FGM/C laws and the consequences of breaking 
these laws, and increasing knowledge about prosecutions and penalties. 
 Lay the foundation for norm change by educating communities and professionals that 
FGM/C is a violation of human rights and raising community awareness about the global 
instruments against FGM/C, notably the United Nation General Assembly and Human 
Rights Council of 2012 and 2014 resolutions [42, 58, 61-63]. 
 Undertake concerted educational interventions involving all stakeholders on the facts 
about FGM/C, thereby counteracting myths that are used to perpetuate the practice, 
such as “FGM/C is supported by religion,” and “the practice makes woman more fertile,” 
among others. 
 Dissociate FGM/C from religion by involving religious leaders and the community through 
capacity building [59].  
 Partner with communities to develop abandonment strategies for FGM/C, including 
participation in documentation, anonymous reporting, monitoring, and tracking of the 
FGM/C practice. 
 Encourage traditional excisors to abandon the practice and empower them to obtain 
income from other means. 
 Empower women and girls through economic opportunities, education for the girl child, 
and dissociation of FGM/C from dowries. 
 Establish anti-FGM/C campaigns among community structures and formal institutions 
like schools and churches to accelerate abandonment. 
 Involve both men and women in the fight against FGM/C, helping them to associate the 
practice with its health consequences and thereby accelerating its abandonment. 
 
 
3.2.4 Strengthening health systems 
Health systems should be strengthened to respond to the health impacts of FGM/C on women 
and girls in the following ways:   
 Develop intervention protocols, given the nature and seriousness of FGM/C 
complications. Cascade protocols to all health care facilities, especially in FGM/C-
prevalent areas. Establish referral and supervisory mechanisms to address those 
complications where expert care is lacking. 
 Integrate FGM/C strategies into existing health care delivery, including reproductive 
health, family planning, and youth-friendly services, among others, to leverage and 
maximize cost effectiveness. 
 Support capacity building for facilities and health care providers, including supervision. 
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 Review curricula in order to benefit health care trainees in training colleges. 
 Provide facilities with equipment and supplies for addressing FGM/C complications.  
 Equip health facilities to be able to deliver health and sexual education to women with 
FGM/C-related complaints. 
 Lobby for the strengthening of the health care system to respond to FGM/C challenges, 
including the establishment of efficient referral systems and the financing and buying of 
supplies. 
 Establish supervisory and referral mechanisms to track and report cases, including 
information on how cases were resolved.   
 Involve professional associations and regulatory bodies to create awareness among 
professional members of complications of FGM/C, including medicalised cutting; illegality 
of FGM/C; and penalties for medicalisation, including de-registration of violators [64, 65].  
 
3.2.5 Documentation and research 
Developing, and facilitating access to, information resources and databanks will be vital to 
designing appropriate responses to specific contexts to address the health impacts of FGM/C. 
From the evidence gathered, the following interventions have been recommended. 
 Research and analyses of the impact on babies and infants who have undergone FGM/C 
are highly recommended. 
 Research into psychological consequences associated with FGM/C needs to be 
prioritized. Too little research has been performed to date to establish the true 
association between FGM/C and psychological disorders. 
 More research is needed that uses rigorous methodological design to further document 
the sexual complications of FGM/C. 
 A large study with a more rigorous methodology is needed to elicit the psycho-social 
consequences of FGM/C and hence inform programming. Multidisciplinary and 
multifactorial causes should also be considered since FGM/C is often one of the factors 
resulting in mental consequences, alongside others such as migration and other past 
violent events. Therefore, consideration of the mental consequences of FGM/C should be 
given priority for research, as should interventions through counseling and 
psychotherapy. 
 Additionally, further research should be conducted on the rare outcomes associated with 
FGM/C.  HIV, STDs, and infertility are rarely encountered in the literature and are not 
reported. Therefore, further research is recommended to establish whether the findings 
may be replicated. Because these medical complications, which are of public health 
importance, are infrequently reported and therefore lack statistical significance, it is 
recommended that high-level methodological research on these complications be 
conducted.  
 Furthermore, more rigorous methodological (case controlled, randomized, and 
longitudinal) and large-scale studies should be conducted in the area of sexual function.  
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3.3 Improvements to enhance pre-service training for frontline health care 
providers 
The analysis revealed various types of gaps in the reference materials. The materials varied in 
the depth and coverage of the details of the FGM/C components (Tables 1 and 2). Whereas the 
materials were strong on background information, they were typically weak on coverage of 
interventions. Of the 44 analysed materials, most (96%; n=42) had detailed background and 
introduction information. The materials scored marginally on obstetric (59%; n=26), gynecologic 
(55%; n=24), counseling (50%; n=22), medicalisation (59%; n=26), and community involvement 
(57%; n=25) themes. The analysis further revealed glaring deficits in the depth of content on the 
skills enhancement and training materials on FGM/C. The materials rated poorly on sexual (43%; 
n=19), psychological/mental (41%; n=18), family planning (25%; n=11), referral procedure (36%; 
n=16), and monitoring and evaluation (25%; n=11) components.  
The analysis demonstrated that the background information, including the epidemiology of 
FGM/C, was well covered in almost all the reference materials. There are numerous studies on 
the “what,” “why,” and “who” questions about FGM/C in an endeavor to understand the practice 
[4]. The components of FGM/C that are critical for interventions and protocols in caring for 
women and girls with health complications, such as obstetric, gynecologic, counseling, 
medicalisation, and research components, were marginally addressed. Furthermore, other 
components such as sexual, psychological, mental health, family planning, referral procedure, 
monitoring, and evaluation components, were poorly covered. This shortcoming could be 
attributed to lack of scientific evidence as a result of poor or no research in these critical areas.  
The components may be suffering neglect due to an underestimation of their magnitude, as a 
result of inadequate evidence and funding. Whereas maternal and child issues have received 
considerable attention and funding, the psychological and sexual impacts of FGM/C have been 
neglected [3, 66]. These shortcomings in the reference materials may have serious implications 
for the management of women and girls living with FGM/C and for the fight against the practice 
in health facility and community settings. There is greater need, therefore, to develop a 
comprehensive, user-friendly training guide and provide skills enhancement support and training 
materials for FGM/C frontline health care professionals working in the curative sector, as well as 
for those in the preventive sectors, to accelerate abandonment of the practice.  
The analyses further revealed glaring gaps in both curative and preventive interventions 
protocols. This is possibly due to the lack of evidence and assessment of interventions for most 
of the identified health outcomes [3]. Several interventions are recommended in order to 
enhance training, programming, and messaging for medical care providers such as: establishing 
referral systems where expert care is lacking, strengthening health care systems to respond to 
FGM/C challenges, and building the capacity of frontline health care professionals to enable 
them to offer curative and preventive services in FGM/C-prevalent areas (Table 7). The findings 
also highlight the importance of anchoring preventive interventions for FGM/C to existing 
community health care systems and socio-community structures, especially in high-prevalence 
areas, in order to address challenges faced by cut girls and women while preventing new FGM/C 
cases. The review findings therefore recommend the development of comprehensive, user-
friendly training guides and resource materials that are suitable for professionals who work in the 
hospital setting (curative) as well as community (preventive) sectors of health.  Furthermore, 
more studies need to be conducted to fill the gaps identified in the health impacts of FGM/C to 
address the methodological pitfalls affecting some of the thematic areas, such as the sexual and 
psychological domains [3]. 
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Table 7: Summary of review findings: Key messages 
Health Impacts 
Recommended Curative and Preventive Interventions  Gaps found in training 
materials, interventions, 
messaging, and research 
on health impacts  
Immediate 
(acute) 
complications 
 Health assessment for early accurate diagnosis of complications 
 Fluid replacement therapy including blood transfusion 
 Anti-pain therapy 
 Immunization against tetanus 
 Antibiotic therapy for infections 
 Surgical management including infection control and prevention 
 Health education (awareness) linking FGM/C to complications 
 Advocacy towards seeking medical assistance and avoidance of traditional herbs  
 Documentation, monitoring, and evaluation, including integration of FGM/C cases into health statistics reporting systems 
 Establishment of efficient referral mechanisms 
 Engagement of all stakeholders to raise awareness among communities about anti-FGM/C laws, implications of breaking these 
laws, and human right violations; clarify myths about the practice; and dissociate the practice from religion 
 Interventions and 
protocols for managing 
women with health 
complications such as 
obstetric and gynecologic 
complications, 
counseling needs, 
medicalisation, and 
research, were 
marginally addressed in 
the materials.  
 Sexual, psychological, 
mental health, family 
planning, referral 
procedure, monitoring, 
and evaluation were 
poorly covered. 
 Documentation, 
information, and access 
to research were absent. 
 Monitoring and 
evaluation of health-
related outcomes were 
rarely documented. 
 Rigorous methodological 
and large-scale studies 
were lacking especially in 
the area of sexual 
function. 
Late (chronic) 
genito-urinary 
problems 
 Health assessment for early accurate diagnosis 
 De-infibulation 
 Surgical/wound care management including plastic surgery 
 Establishment of efficient and referral mechanisms 
 Antibiotic therapy for infections 
 Infection control and prevention 
 Health education 
 Fistula identification, management, and care 
 Documentation, monitoring, and evaluation  
Obstetric 
complications 
 Health assessment for accurate diagnosis including types of FGM/C and re-infibulation cases 
 Psychological and counseling support 
 De-infibulation 
 Surgical/wound care management  
 Establishment of efficient and referral mechanisms for complicated dermoid cysts, keloids, and scarring at the time of 
pregnancy 
 Antibiotic therapy for urinary infections 
 Infection control and prevention 
 Health education, including on hospital delivery, association between FGM/C and complications, avoiding use of herbs 
 Blood balance maintenance through bleeding control, fluid replacement, blood transfusion, hematinics 
 Documentation, monitoring, and evaluation 
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Sexual 
functioning 
complications  
 Health assessment for accurate diagnosis of sexual complications 
 Psychosexual and counseling support 
 Health education including sexual education linking FGM/C with sexual dysfunction  
 Establishment of efficient and effective referral mechanisms including linkages with sexologists 
 Implementation of high-quality methodological research 
 Documentation, monitoring, and evaluation 
Psycho-social 
complications 
 
 Health assessment for accurate diagnosis of psycho-social complications 
 Psycho-social and counseling support 
 Establishment of efficient and effective referral mechanisms for psychiatric/psychological/counseling and complicated cases 
 Health education linking FGM/C with psycho-social problems 
 Cognitive behavioral therapy to prevent and manage post-traumatic stress disorder 
 Routine screening and management programs for psycho-social complications 
 Establishment of institutional, peer, and community support groups 
 Implementation of high-quality methodological research on psycho-social problems 
 Documentation, monitoring, and evaluation 
Recommended improvements to enhance pre-service training for frontline health care providers 
 Initiate health care professionals’ training through engagement with regulatory bodies to allow for curricula review, then develop interventional/training materials for pre/in-
service and reference materials on FGM/C. This will enable the providers to manage for FGM/C-exposed women, raise awareness to prevent new cutting, and empower them 
to resist medicalisation, including re-infibulation. 
 Strengthen the health care system to respond to women exposed to FGM/C and to prevent girls from being cut, through the following approaches: 
 Stock health facilities with necessary supplies and equipment. 
 Train health care providers on FGM/C services through continuous professional development. 
 Develop, cascade, display, and update FGM/C management protocols. 
 Integrate FGM/C into existing health care programs (e.g., antenatal care, youth friendly, and family planning services). 
 Promote task shifting for nurses, midwives, medical assistants, and medical officers. In hard to reach areas where doctors and specialists are not available, nurses and 
midwives should be allowed to perform lifesaving interventions such as de-infibulation, which may not be within their professional jurisdictions, without risk of litigation. This 
shift is possible through lobbying of stakeholders, especially regulatory bodies, to review their requirements and mandates for specific professionals.  
 Lobby for inclusion of FGM/C statistics in the health statistics reporting system to promote tracking, monitoring, and evaluation that will influence planning, decisionmaking, 
and funding at the county and national government levels and for donors. 
 Establish facilitating supervisory mechanisms to enable professionals to provide management and ensure that the health care system is well capacitated to respond to FGM/C 
challenges. 
 Establish a databank for complications across the spectrum associated with FGM/C with hospitals  
 Support health systems and specialists to manage the above-mentioned databank and to track the outcomes of interventions to manage complications (for monitoring, 
evaluation, and review purposes). 
 Support de-medicalisation, including no re-infibulation for women. 
 Increase cultural competence on language and sensitivity of FGM/C as a highly cultural issue. 
 Research the sexual, psychological, and social complications to inform policy, practice, and programming. 
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CONCLUSION 
 
The health impacts of FGM/C have received different levels of attention, both in terms of 
interventions and evidence. Based on these recommendations, there is a need to communicate 
this evidence base to a range of stakeholders, taking into consideration that key messages are 
carefully crafted to ensure appropriate interpretation and guidance for action. This approach is 
especially important when using this evidence for medical and behaviour change interventions, 
given the sometimes less than successful responses to health messaging observed over the past 
decade. Information on the health consequences would be of most use in both hospital facilities 
and community settings [56, 65] to help in providing appropriate gynecological and obstetric 
services and medical treatment to women and girls immediately following cutting. This objective 
can be achieved through health care provider training and skills empowerment, health system 
strengthening, documentation and research on FGM/C issues. The health care system 
strengthening should therefore include establishment of an efficient and effective referral system 
where expertise may be lacking in order to support corrective and preventive interventions for 
FGM/C in all settings.  
Building the capacity of frontline health care professionals to offer curative and preventive 
services in FGM/C-prevalent areas in both hospital and community settings may be enhanced 
through lobbying for curricula review and development of training manuals and guidelines. 
Anchoring preventive interventions for FGM/C to existing health care programs and socio-
community structures, especially in high-prevalence areas, will be a promising approach to 
address challenges faced by cut girls and women while preventing new cutting. Furthermore, 
large-scale, high-quality methodological studies are recommended for specific neglected 
complications (sexual, psychological, and mental) associated with FGM/C to inform future 
preventive and corrective programs. Additionally, curative and preventive strategies for protecting 
girls and women from cutting need to be initiated and escalated at the socio-community level. 
Raising awareness of the relationship between FGM/C and health problems may increase health 
seeking behaviour and reporting, aiding early identification and management before 
complications set in.  
The health impacts resulting from FGM/C place a burden on health systems, however, little is 
known of the costs, especially of the obstetric complications associated with FGM/C [67]. While 
this synthesis focused on interventions that may facilitate effective responses to women and girls 
exposed to the practice and promote its prevention, it is critical to also consider the cost 
effectiveness of the interventions for planning and programming purposes.  
 
Furthermore, the recommended interventions for preventing and addressing FGM/C in this 
synthesis not only seek to address FGM/C as a practice rooted in gender-based discrimination 
and social norms but also other forms of violence against women and girls [68, 69]. 
 
Women’s health is a human rights issue and women’s empowerment cannot be separated from 
issues related to women’s health [70]. Moving forward, Evidence to End FGM/C: Research to 
Help Girls and Women Thrive plans to collaborate with policymakers, development partners, 
professional regulatory bodies, trainers, and other key stakeholders to review the curricula and 
related materials for health professionals before the much-needed training materials and 
guidelines for health care providers can be drafted; and to conduct new research to deepen 
understanding of all the health impacts of FGM/C and their interventions. 
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